Get started
PHAXIAM THERAPEUTICSPHAXIAM THERAPEUTICSPHAXIAM THERAPEUTICS

PHAXIAM THERAPEUTICS

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

PHXM fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

PHAXIAM Therapeutics SA operates as a biopharmaceutical company. It engages in the development of treatments for resistant bacterial infections. The firm develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to combat bacterial infections in humans, particularly those resistant to antibiotics. The company was founded in 2004 and is headquartered in Lyon, France.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
PHXM has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company